Key statistics
On Tuesday, Nuvation Bio Inc (NUVB:NYQ) closed at 2.89, -30.53% below its 52-week high of 4.16, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.85 |
---|---|
High | 2.98 |
Low | 2.83 |
Bid | 2.84 |
Offer | 3.16 |
Previous close | 2.80 |
Average volume | 2.95m |
---|---|
Shares outstanding | 336.57m |
Free float | 245.48m |
P/E (TTM) | -- |
Market cap | 942.39m USD |
EPS (TTM) | -2.17 USD |
Data delayed at least 15 minutes, as of Nov 26 2024.
More ▼
- Nuvation Bio to Present at the Jefferies London Healthcare Conference
- Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
- Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer
- Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024
- Nuvation Bio to Present at the Cantor Global Healthcare Conference
More ▼